IR-Med, Inc. announced that it has entered into a subscription agreement with certain investors for private placement of 3,636,364 common stock at a per share price of $0.88 and warrants to purchase up to an additional 3,636,364 shares of common stock at a per share exercise price of $1.10 for aggregate gross proceeds of $3,200,000 on April 11, 2022. The warrants are exercisable for two years from the date of issuance and entitle the holders to purchase up to 3,636,364 shares of Common Stock and have an exercise price of $1.10 per share. However, the Company is entitled to expedite the Warrant exercise period for all or a part of the then outstanding Warrants by written notice to the Investors if the publicly traded price of the Company's Common Stock equals or exceeds $2.50 per share and the corresponding average daily trading volume during such period shall equal or exceed 75,000 shares, in each case for the 40 consecutive trading days.

The company will issue securities pursuant to exemption provided under Regulation D.